Late-life dementias: does this unyielding global challenge require a broader view?
Montine
Thomas J
TJ
Larson
Eric B
EB
D000375:Aging; D000544:Alzheimer Disease / Q000097:blood / Q000188:drug therapy* / Q000453:epidemiology* / Q000473:pathology; D053829:Amyloid Precursor Protein Secretases / Q000037:antagonists & inhibitors*; D016229:Amyloid beta-Peptides; D015897:Comorbidity; D017281:Cost of Illness; D003704:Dementia; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D005480:Flurbiprofen / Q000627:therapeutic use*; D014943:Global Health; D006801:Humans; D020738:Leptin / Q000097:blood*; D008136:Longevity; D010446:Peptide Fragments
D016229:Amyloid beta-Peptides; D004791:Enzyme Inhibitors; D020738:Leptin; D010446:Peptide Fragments; C505522:tarenflurbil; D005480:Flurbiprofen; D053829:Amyloid Precursor Protein Secretases